PROMETHEUS BIOSCIENCES INC (RXDX)

US74349U1088 - Common Stock

199.92  +0.18 (+0.09%)

After market: 199.95 +0.03 (+0.02%)

Buy % Consensus

72

ChartMill assigns a Buy % Consensus number of 72% to RXDX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 198.9. This target is -0.51% below the current price.
RXDX was analyzed by 15 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about RXDX.
In the previous month the buy percentage consensus was at a similar level.
RXDX was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 199.92161.60204.00198.90210.00 - -19.17% 2.04% -0.51% 5.04%
Up and Down Grades
Date Firm Action Rating
2023-05-10 RBC Capital Maintains Sector Perform
2023-05-10 Jefferies Downgrade Buy -> Hold
2023-04-18 RBC Capital Downgrade Outperform -> Sector Perform
2023-04-18 Wells Fargo Downgrade Overweight -> Equal-Weight
2023-04-18 Credit Suisse Downgrade Outperform -> Neutral
2023-04-18 Piper Sandler Downgrade Overweight -> Neutral
2023-04-17 Guggenheim Downgrade Buy -> Neutral
2023-04-17 Stifel Downgrade Buy -> Hold
2023-03-06 Guggenheim Maintains Buy
2023-03-01 Oppenheimer Maintains Outperform
2023-03-01 Credit Suisse Maintains Outperform
2023-01-31 Goldman Sachs Maintains Buy
2022-12-08 BTIG Maintains Buy
2022-12-08 Oppenheimer Maintains Outperform
2022-12-08 RBC Capital Maintains Outperform
2022-12-08 Credit Suisse Maintains Outperform
2022-11-01 Stifel Maintains Buy
2022-10-04 Oppenheimer Maintains Outperform
2022-10-04 RBC Capital Maintains Outperform
2022-10-03 BTIG Maintains Buy
2022-08-29 Wells Fargo Maintains Overweight
2022-08-29 Piper Sandler Maintains Overweight
2022-08-12 SVB Leerink Maintains Outperform
2022-08-12 Credit Suisse Maintains Outperform
2022-07-20 Goldman Sachs Initiate Buy
2022-06-10 Piper Sandler Initiate Overweight
2022-05-13 RBC Capital Maintains Outperform
2022-05-13 Wells Fargo Maintains Overweight
2022-03-10 SVB Leerink Maintains Outperform
2022-03-10 Wells Fargo Maintains Overweight